| Literature DB >> 23405065 |
Adrien Boillot1, Sophia Zoungas, Paul Mitchell, Ronald Klein, Barbara Klein, Mohammad Kamran Ikram, Caroline Klaver, Jie Jin Wang, Bamini Gopinath, E Shyong Tai, Aljoscha Steffen Neubauer, Serge Hercberg, Laima Brazionis, Seang-Mei Saw, Tien-Yin Wong, Sébastien Czernichow.
Abstract
BACKGROUND: Overweight and obesity are thought to significantly influence a person's risk of cardiovascular disease, possibly via its effect on the microvasculature. Retinal vascular caliber is a surrogate marker of microvascular disease and a predictor of cardiovascular events. The aim of this systematic review and meta-analysis was to determine the association between body mass index (BMI) and retinal vascular caliber. METHODS ANDEntities:
Mesh:
Year: 2013 PMID: 23405065 PMCID: PMC3566162 DOI: 10.1371/journal.pone.0052708
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of studies included in the meta-analysis.
| Study Ref | Cohort study | Country | Study size | Age (mean±sd) | Level of adjustment |
| Cheung N et al., 2007 (24) | Singapore Cohort Study of Risk Factors for Myopia (SCORM) | Singapore | 1153 | 13.7±1.2 | Age, gender, race, systolic blood pressure, diastolic blood pressure, eye measurements. |
| Gopinath B et al., 2011 (25) | Sydney Childhood Eye Study (SCES12yr) | Australia | 2353 | 12.7±0.4 | Age, gender, race, hypertension |
| Hughes A et al., 2009 (30) | Beaver Dam Eye Study cohort (BDES) | USA | 4659 | 61.5±10.9 | Age, gender, race, smoking, hypertension, type 2 diabetes mellitus, HDL cholesterol |
| Ikram M et al., 2004 (16) | Rotterdam Study | The Netherlands | 5602 | 67.9±8.1 | Age, gender, mean arterial blood pressure, non-fasting blood glucose, total cholesterol, smoking. |
| Jeganathan V et al., 2009 (28) | Singapore Prospective Study Program and Singapore Cardiovascular Cohort Study 2 (SPSP/SCCS2) | Singapore | 3600 | 49.4±11.3 | Age, gender, race, systolic blood pressure, smoking, cholesterol, HbA1c |
| Klein R et al., 2003 (23) | The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII (WESDR/T1DM) | USA | 797 | 33.2±12.0 | Age, gender, race, smoking, hypertension. |
| Klein R et al., 2006 (7) | The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XX (WESDR/T2DM) | USA | 1362 | 66.6±11.3 | Age, gender, race, smoking, hypertension. |
| Liew G et al., 2008 (26) | Atherosclerosis Risk in Communities (ARIC) | USA | 10778 | 59.7±5.6 | Age, gender, race, diabetes medication, insulin use, glucose level, smoking, HDL, cholesterol, hypertension, medication for hypertension. |
| Sun C et al., 2008 (29) | Singapore Malay Eye Study (SIMES) | Singapore | 3001 | 57.7±10.6 | Age, gender, systolic blood pressure, HbA1c, smoking, cholesterol. |
| Taylor B et al., 2007 (9) | Sydney Childhood Eye Study (SCES6yr) | Australia | 1773 | 6.7±0.4 | Age, gender, race, hypertension. |
| Wang JJ et al., 2006 (27) | The Blue Mountains Eye Study (BMES) | Australia | 3295 | 65.5±9.4 | Age, gender, smoking, hypertension, type 2 diabetes mellitus. |
| Wong TY et al., 2006 (22) | The Multi-Ethnic Study of Atherosclerosis (MESA) | USA | 5885 | 63.0±9.9 | Age, gender, race, family history of type 2 diabetes mellitus, glucose level, insulin use, smoking, HDL, LDL, triglycerides, exercise, hypertension, medication for hypertension. |
Figure 1Flow-chart identifying eligible studies.
Figure 2Adjusted adult mean retinal vascular values across BMI categories (maximum level of adjustment. CRAE (A); CRVE (B)).
Crude mean retinal vascular values across BMI categories.
| <18.5 vs [18.5; 24.99] | [18.5; 24.99] vs [25; 29.99] | [18.5; 24.99] vs ≥30 | ||||
| Mean difference (95% CI) (μm) | Heterogeneity (I2) | Mean difference (95% CI) (μm) | Heterogeneity (I2) | Mean difference (95% CI) (μm) | Heterogeneity (I2) | |
|
| ||||||
|
| 3.25 [1.70, 4.80]† | 22% | −1.04 [−1.62, −0.47]† | 53% | −1.35 [−2.42, −0.28]† | 82% |
|
| −0.73 [−3.63, 2.16] | 56% | 1.54 [0.32, 2.76]† | 81% | 3.03 [1.04, 5.03]† | 90% |
|
| ||||||
|
| 1.89 [−1.13, 4.91] | 87% | −1.44 [−2.90, 0.02] | 56% | −1.59 [−4.18, 1.00] | 63% |
|
| 0.31 [−3.26, 3.89] | 82% | 2.26 [0.90, 3.61]† | 0% | 6.54 [3.07, 10.02]† | 62% |
(1) *: p<0.05. †: p<0.01. <18.5 vs [18.5; 24.99]: n = 13642. [18.5; 24.99] vs [25; 29.99]: n = 28200. [18.5; 24.99] vs ≥30: n = 23069.
(2) *: p<0.05. †: p<0.01. <18.5 vs [18.5; 24.99]: n = 4004. [18.5; 24.99] vs [25; 29.99]: n = 4202. [18.5; 24.99] vs ≥30: n = 3647.
Figure 3Association between overweight (BMI between 25.0 and 29.9 kg/m2) and CRAE (A), and CRVE (B) in adults (maximum level of adjustment).
Figure 4Association between obesity (BMI >30.0 kg/m2) and CRAE (A), and CRVE (B) in adults (maximum level of adjustment).